Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trialIvan Fan-Ngai Hung, Kwok-Yung Yuen, Tom Wai‐Hin Chung et al.|The Lancet|2020Cited by 1.6k
Development of Conventional and Real-Time Quantitative PCR Assays for Diagnosis and Monitoring of ScabiesSamson S. Y. Wong, Kwok‐Yung Yuen, Sandy Ka‐Yee Chau et al.|Journal of Clinical Microbiology|2015Cited by 57